Treatment of Binge Eating in Obese Patients in Primary Care

• Status: Completed
• Trial end date: 2012-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will test the effectiveness of two empirically-supported but distinct treatments for recurrent binge eating in obese patients: 1) Cognitive Behavior Therapy, using a pure self-help approach and 2) sibutramine, an anti-obesity medication also found to have efficacy for binge eating. Self-help Cognitive Behavior Therapy and sibutramine will be administered alone and in combination in a primary care setting.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yale University
• Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institutes of Health (NIH)
• Treatments: Sibutramine

Criteria

Inclusion Criteria:

• Obese (BMI >= 30)

Exclusion Criteria:

• Medication regimen that represents medical contraindication to sibutramine

• Serious unstable or uncontrolled medical conditions that represent contraindication to sibutramine

• Pregnancy